BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 11002763)

  • 1. Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity.
    McCluggage WG; Patterson A; Maxwell P
    J Clin Pathol; 2000 Aug; 53(8):603-5. PubMed ID: 11002763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive angiomyxoma of the vulva: expression of estroprogestinic receptors and follow-up.
    De Salvia D; Fais GF; Lauri F; Brotto M; Petrillo G; Salmaso R
    Clin Exp Obstet Gynecol; 1998; 25(4):141-3. PubMed ID: 9987573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive angiomyxoma: reappraisal of its relationship to angiomyofibroblastoma in a series of 16 cases.
    Granter SR; Nucci MR; Fletcher CD
    Histopathology; 1997 Jan; 30(1):3-10. PubMed ID: 9023551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive angiomyxoma presenting as a vulval polyp.
    Srinivasan R; Mohapatra N; Malhotra S; Rao SK
    Indian J Cancer; 2007; 44(2):87-9. PubMed ID: 17938485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare paratesticular aggressive angiomyxoma with negative oestrogen and progesterone receptors in a male patient.
    Neyaz A; Husain N; Anand N; Srivastava P
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29866663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy.
    McCluggage WG; Jamieson T; Dobbs SP; Grey A
    Gynecol Oncol; 2006 Mar; 100(3):623-5. PubMed ID: 16246403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and progesterone receptors in normal and malignant vulvar tissue.
    Omsjö IH; Wright PB; Börmer OP
    Gynecol Obstet Invest; 1984; 17(6):281-3. PubMed ID: 6745735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular angiofibroma and related fibromatous lesions of the vulva: report of a series of cases with a morphological spectrum wider than previously described.
    McCluggage WG; Ganesan R; Hirschowitz L; Rollason TP
    Histopathology; 2004 Oct; 45(4):360-8. PubMed ID: 15469474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of angiomyofibroblastoma and aggressive angiomyxoma in both sexes: four cases composed of bimodal CD34 and factor XIIIa positive dendritic cell subsets.
    Silverman JS; Albukerk J; Tamsen A
    Pathol Res Pract; 1997; 193(10):673-82. PubMed ID: 9505259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggressive Angiomyxoma. A case series of eight years of experience.
    Gorgulu G; Kole MÇ; Ayaz D; Kuru O; Gokcu M; Sanci M
    Ann Ital Chir; 2022; 93():562-565. PubMed ID: 36353852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up.
    van Roggen JF; van Unnik JA; Briaire-de Bruijn IH; Hogendoorn PC
    Virchows Arch; 2005 Feb; 446(2):157-63. PubMed ID: 15735978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiomyofibroblastoma of the vulva. A benign neoplasm distinct from aggressive angiomyxoma.
    Fletcher CD; Tsang WY; Fisher C; Lee KC; Chan JK
    Am J Surg Pathol; 1992 Apr; 16(4):373-82. PubMed ID: 1314521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA2 Is a Useful Marker of Vulvovaginal Aggressive Angiomyxoma But May Be Positive in Other Mesenchymal Lesions at This Site.
    Harkness R; McCluggage WG
    Int J Gynecol Pathol; 2021 Mar; 40(2):185-189. PubMed ID: 32897956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggressive angiomyxoma of the pelvioperineal region. Immunohistological and ultrastructural study of seven cases.
    Skálová A; Michal M; Husek K; Zámecník M; Leivo I
    Am J Dermatopathol; 1993 Oct; 15(5):446-51. PubMed ID: 8238780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive angiomyxoma of male genital region. Report of 4 cases with immunohistochemical evaluation including hormone receptor status.
    Idrees MT; Hoch BL; Wang BY; Unger PD
    Ann Diagn Pathol; 2006 Aug; 10(4):197-204. PubMed ID: 16844560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients.
    Fetsch JF; Laskin WB; Lefkowitz M; Kindblom LG; Meis-Kindblom JM
    Cancer; 1996 Jul; 78(1):79-90. PubMed ID: 8646730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aggressive angiomyxoma of the vulva presenting as a huge pedunculated tumor].
    Obst M; Suchocki S
    Ginekol Pol; 2011 Jan; 82(1):68-70. PubMed ID: 21473058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term response to hormone therapy in a young woman with aggressive pelvic angiomyxoma.
    Walczak K; Luczynska K; Kupryjanczyk J; Duchnowska R
    Ginekol Pol; 2021; 92(1):82-83. PubMed ID: 33448013
    [No Abstract]   [Full Text] [Related]  

  • 19. Aggressive angiomyxoma of pelvic soft parts: a clinicopathologic study of nine cases.
    Bégin LR; Clement PB; Kirk ME; Jothy S; McCaughey WT; Ferenczy A
    Hum Pathol; 1985 Jun; 16(6):621-8. PubMed ID: 3997139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma.
    McCluggage WG; Connolly L; McBride HA
    Am J Surg Pathol; 2010 Jul; 34(7):1037-42. PubMed ID: 20551826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.